Cargando…
Progress in research on paclitaxel and tumor immunotherapy
Paclitaxel is a well-known anticancer agent with a unique mechanism of action. It is considered to be one of the most successful natural anticancer drugs available. This study summarizes the recent advances in our understanding of the sources, the anticancer mechanism, and the biosynthetic pathway o...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567594/ https://www.ncbi.nlm.nih.gov/pubmed/31223315 http://dx.doi.org/10.1186/s11658-019-0164-y |
_version_ | 1783427111627784192 |
---|---|
author | Zhu, Linyan Chen, Liqun |
author_facet | Zhu, Linyan Chen, Liqun |
author_sort | Zhu, Linyan |
collection | PubMed |
description | Paclitaxel is a well-known anticancer agent with a unique mechanism of action. It is considered to be one of the most successful natural anticancer drugs available. This study summarizes the recent advances in our understanding of the sources, the anticancer mechanism, and the biosynthetic pathway of paclitaxel. With the advancement of biotechnology, improvements in endophytic fungal strains, and the use of recombination techniques and microbial fermentation engineering, the yield of extracted paclitaxel has increased significantly. Recently, paclitaxel has been found to play a large role in tumor immunity, and it has a great potential for use in many cancer treatments. |
format | Online Article Text |
id | pubmed-6567594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65675942019-06-20 Progress in research on paclitaxel and tumor immunotherapy Zhu, Linyan Chen, Liqun Cell Mol Biol Lett Review Letter Paclitaxel is a well-known anticancer agent with a unique mechanism of action. It is considered to be one of the most successful natural anticancer drugs available. This study summarizes the recent advances in our understanding of the sources, the anticancer mechanism, and the biosynthetic pathway of paclitaxel. With the advancement of biotechnology, improvements in endophytic fungal strains, and the use of recombination techniques and microbial fermentation engineering, the yield of extracted paclitaxel has increased significantly. Recently, paclitaxel has been found to play a large role in tumor immunity, and it has a great potential for use in many cancer treatments. BioMed Central 2019-06-13 /pmc/articles/PMC6567594/ /pubmed/31223315 http://dx.doi.org/10.1186/s11658-019-0164-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Letter Zhu, Linyan Chen, Liqun Progress in research on paclitaxel and tumor immunotherapy |
title | Progress in research on paclitaxel and tumor immunotherapy |
title_full | Progress in research on paclitaxel and tumor immunotherapy |
title_fullStr | Progress in research on paclitaxel and tumor immunotherapy |
title_full_unstemmed | Progress in research on paclitaxel and tumor immunotherapy |
title_short | Progress in research on paclitaxel and tumor immunotherapy |
title_sort | progress in research on paclitaxel and tumor immunotherapy |
topic | Review Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567594/ https://www.ncbi.nlm.nih.gov/pubmed/31223315 http://dx.doi.org/10.1186/s11658-019-0164-y |
work_keys_str_mv | AT zhulinyan progressinresearchonpaclitaxelandtumorimmunotherapy AT chenliqun progressinresearchonpaclitaxelandtumorimmunotherapy |